Sponsor:
NYU Langone Health
Code:
NCT05786443
Conditions
End Stage Renal Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Empagliflozin 10 MG
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-11. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2025-12-04.